This inventor holds 3 USPTO granted patents. Top assignee: Eli Lilly and Company. Active years: 1996-2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Indianapolis, IN (US) (1996)
- Greenwood, IN (US) (1999 - 2005)
Company Filing History:
Years Active: 1996-2005
Title: The Innovations of Adam Joseph Kreuzman
Introduction
Adam Joseph Kreuzman is a notable inventor based in Greenwood, IN (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel antibiotics. With a total of 3 patents to his name, Kreuzman is recognized for his innovative approaches to combating bacterial infections.
Latest Patents
Kreuzman's latest patents include groundbreaking work on lipoglycopeptide antibiotics. These novel lipoglycopeptides exhibit bacterial signal peptidase inhibitory activity, providing a new avenue for treating bacterial infections. The invention also encompasses actinomycete strains that produce these lipoglycopeptides, methods for culturing these strains, and pharmaceutical compositions that utilize these compounds. This innovation holds promise for both human and veterinary medicine.
Another significant patent by Kreuzman is related to the deacylation process of teicoplanin. This invention focuses on deacyl teicoplanin and outlines a process for preparing it by reacting teicoplanin with ECB deacylase. The resulting deacyl teicoplanin can be further alkylated to produce compounds that are useful for their antibacterial activity.
Career Highlights
Kreuzman is currently employed at Eli Lilly and Company, where he continues to advance his research in pharmaceuticals. His work has been instrumental in developing new treatments that address pressing health concerns related to bacterial infections.
Collaborations
Throughout his career, Kreuzman has collaborated with esteemed colleagues, including Wu-Kuang Yeh and Matthew David Belvo. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Adam Joseph Kreuzman exemplifies the spirit of innovation in the pharmaceutical industry. His contributions, particularly in the development of novel antibiotics, highlight the importance of research and collaboration in addressing global health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile